InfraReDx to Present at Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference
BURLINGTON, Mass., Dec. 3, 2010 /PRNewswire/ -- InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that James E. Muller, M.D., founder and chief executive officer, will be presenting at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference, to be held December 7-8, 2010, at the Nikko Hotel in San Francisco.
The InfraReDx presentation is scheduled to take place on Tuesday, December 7 at 4:00 p.m. PST. A live audio webcast will be available through the Media Center on the corporate website, www.infraredx.com. This webcast will be archived following the live event.
About InfraReDx, Inc.InfraReDx, Inc. is a privately funded medical device company improving patient care through the development and commercialization of intelligent imaging technologies to improve the diagnosis and treatment of coronary artery disease. InfraReDx's LipiScan™ IVUS Coronary Imaging System is the first and only available catheter to combine both near-infrared spectroscopy (NIR) and intravascular ultrasound (IVUS) technologies to both visualize and characterize the intracoronary lipid core plaques (LCP) suspected of causing the majority of heart attacks. Founded in 1998, InfraReDx is headquartered in Burlington, Massachusetts. For more information, visit www.infraredx.com. Contacts: